Cancer news

An immunotherapy for some patients with advanced skin cancer and a targeted drug for some women with breast cancer have been approved for NHS Scotland.

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England.

A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.

People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.

Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.

Combining a targeted drug with hormone therapy could extend survival for some women with advanced breast cancer, according to new trial results.

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results.